Helsinki, FinlandJan 2026
Avenue Biosciences raised €4.9M in a Seed round in Jan 2026. The company is based in Helsinki, Finland. Investors in the round: Balnord, Dimerent, Inventure and 3 others. Data as of Nov 2026.
Amount raised
€4.9M
€4,875,128
Native amount
5,700,000 USD
Stage
Seed
seed
Investors
6
Provenance & confidence
High confidenceAmount
5,700,000 USD
ECB-at-date → €4.9M · rate 1.1692 on 2026-01-12
High confidence
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
Investors in this round
6 namedDate
Jan 2026
Round type
seed
Amount (EUR)
€4.9M